$MCS
MARCUS CORP Stock $mcs

$mcs Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000006223422000010 Filed on March 03, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$169.0M	$92.55M	$458.2M
YoY Change	360.62%	175.51%	92.79%
Cost Of Revenue	$98.04M	$57.21M	$274.5M
YoY Change	194.41%	92.62%	47.18%
Gross Profit	$71.01M	$35.34M	$183.7M
YoY Change	1988.47%	806.1%	259.58%
Gross Profit Margin	42.0%	38.18%	40.1%
Selling, General & Admin	$33.10M	$30.59M	$123.5M
YoY Change	28.81%	16.77%	9.77%
% of Gross Profit	46.62%	86.58%	67.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.92M	$18.48M	$72.04M
YoY Change	-3.11%	-1.19%	-4.03%
% of Gross Profit	25.24%	52.28%	39.21%
Operating Expenses	$54.93M	$57.72M	$219.4M
YoY Change	26.56%	12.95%	7.09%
Operating Profit	$16.08M	-$26.11M	-$41.45M
YoY Change	-140.2%	-45.59%	-76.77%
Interest Expense	-$3.998M	$4.907M	$18.70M
YoY Change	-29.86%	18.76%	14.91%
% of Operating Profit	-24.86%
Other Income/Expense, Net	-$629.0K	-$5.579M	-$17.54M
YoY Change	-178.63%	-6.41%	0.93%
Pretax Income	$9.674M	-$31.69M	-$58.99M
YoY Change	-116.4%	-41.26%	-69.87%
Income Tax	$3.230M	-$8.323M	-$15.70M
% Of Pretax Income	33.39%
Net Earnings	$6.444M	-$23.37M	-$43.29M
YoY Change	-116.52%	-40.76%	-65.32%
Net Earnings / Revenue	3.81%	-25.25%	-9.45%
Basic Earnings Per Share
Diluted Earnings Per Share	$205.1K	-$744.0K	-$1.381M
COMMON SHARES
Basic Shares Outstanding		31.40M shares	31.36M shares
Diluted Shares Outstanding		31.40M shares	31.36M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.66M	$8.667M	$17.66M
YoY Change	163.55%	5.7%	163.55%
Cash & Equivalents	$17.66M	$8.629M	$17.66M
Short-Term Investments
Other Short-Term Assets	$15.36M	$14.36M	$26.62M
YoY Change	47.65%	25.12%	21.53%
Inventory	$4.913M
Prepaid Expenses
Receivables	$8.981M	$11.30M	$8.981M
Other Receivables	$19.92M	$24.87M	$46.69M
Total Short-Term Assets	$99.95M	$83.97M	$99.95M
YoY Change	47.38%	-8.42%	47.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$988.3M	$1.032B	$988.3M
YoY Change	16.5%	-7.35%	-8.32%
Goodwill	$75.10M	$75.12M
YoY Change	-0.12%	-0.12%
Intangibles
YoY Change
Long-Term Investments	$2.335M	$0.00	$2.335M
YoY Change	11.19%	-100.0%	11.19%
Other Assets	$12.69M	$12.17M	$15.73M
YoY Change	-59.2%	-63.22%	-33.89%
Total Long-Term Assets	$1.088B	$1.105B	$1.088B
YoY Change	-8.26%	-9.77%	-8.26%
TOTAL ASSETS
Total Short-Term Assets	$99.95M	$83.97M	$99.95M
Total Long-Term Assets	$1.088B	$1.105B	$1.088B
Total Assets	$1.188B	$1.189B	$1.188B
YoY Change	-5.25%	-9.68%	-5.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.78M	$21.14M	$35.78M
YoY Change	171.93%	33.6%	171.07%
Accrued Expenses	$116.5M	$109.2M	$116.5M
YoY Change	12.36%	10.45%	12.36%
Deferred Revenue
YoY Change
Short-Term Debt	$47.35M	$83.50M	$47.35M
YoY Change	-45.7%	-7.15%	-45.7%
Long-Term Debt Due	$10.97M	$11.71M	$13.53M
YoY Change	3.97%	-9.4%	1.71%
Total Short-Term Liabilities	$213.2M	$188.3M	$213.2M
YoY Change	-1.94%	-14.63%	-1.95%
LONG-TERM LIABILITIES
Long-Term Debt	$204.2M	$236.6M	$221.4M
YoY Change	5.77%	18.69%	4.03%
Other Long-Term Liabilities	$274.0M	$285.4M	$274.0M
YoY Change	-6.12%	-1.74%	-6.12%
Total Long-Term Liabilities	$204.2M	$236.6M	$495.4M
YoY Change	5.77%	18.69%	-1.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$213.2M	$188.3M	$213.2M
Total Long-Term Liabilities	$204.2M	$236.6M	$495.4M
Total Liabilities	$417.3M	$424.9M	$734.7M
YoY Change	1.69%	1.19%	-2.75%
SHAREHOLDERS EQUITY
Retained Earnings	$289.3M	$282.9M
YoY Change	-12.83%	-23.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.379M	$1.528M
YoY Change	-53.41%	-51.1%
Treasury Stock Shares	48.11K shares	$48.79K
Shareholders Equity	$453.6M	$442.3M	$453.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.188B	$1.189B	$1.188B
YoY Change	-5.25%	-9.68%	-5.25%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	$6.444M	-$23.37M	-$43.29M
YoY Change	-116.52%	-40.76%	-65.32%
Depreciation, Depletion And Amortization	$17.92M	$18.48M	$72.04M
YoY Change	-3.11%	-1.19%	-4.03%
Cash From Operating Activities	$44.19M	$3.319M	$46.25M
YoY Change	268.28%	-112.96%	-167.47%
INVESTING ACTIVITIES
Capital Expenditures	-$7.961M	-$4.695M	$17.08M
YoY Change	194.85%	67.68%	-20.04%
Acquisitions			$0.00
YoY Change
Other Investing Activities	$9.596M	-$1.650M	$461.0K
YoY Change	317.22%	-650.0%	-202.44%
Cash From Investing Activities	$1.635M	-$6.345M	$10.88M
YoY Change	-508.75%	144.04%	-190.14%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$10.72M
YoY Change			13.44%
Cash From Financing Activities	-36.75M	5.268M	-$47.17M
YoY Change	155.21%	-112.25%	-168.26%
NET CHANGE
Cash From Operating Activities	44.19M	3.319M	$46.25M
Cash From Investing Activities	1.635M	-6.345M	$10.88M
Cash From Financing Activities	-36.75M	5.268M	-$47.17M
Net Change In Cash	9.079M	2.242M	$9.966M
YoY Change	-424.25%	-103.15%	-186.44%
FREE CASH FLOW
Cash From Operating Activities	$44.19M	$3.319M	$46.25M
Capital Expenditures	-$7.961M	-$4.695M	$17.08M
Free Cash Flow	$52.15M	$8.014M	$29.17M
YoY Change	254.8%	-135.15%	-132.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000062234
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-30
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-12604
CY2021	dei	Entity Registrant Name EntityRegistrantName	MARCUS CORP
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WI
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	39-1139844
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 East
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Wisconsin Avenue
CY2021	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 1900
CY2021	dei	Security12b Title Security12bTitle	Common stock, $1.00 par value
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Milwaukee
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	53202-4125
CY2021	dei	City Area Code CityAreaCode	414
CY2021	dei	Local Phone Number LocalPhoneNumber	905-1000
CY2021	dei	Trading Symbol TradingSymbol	MCS
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Public Float EntityPublicFloat	499866526	USD
CY2021	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2021	dei	Auditor Location AuditorLocation	Milwaukee, Wisconsin
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17658000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6745000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6396000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7343000	USD
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	28902000	USD
CY2020Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	6359000	USD
CY2021Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	4335000	USD
CY2020Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	4913000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	22435000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	27934000	USD
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4856000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4117000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	15364000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10406000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	99946000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	67817000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	771192000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	848328000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217072000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	229660000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2335000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2084000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	75095000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	75188000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10032000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12689000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31101000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	100151000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	108373000	USD
CY2021Q4	us-gaap	Assets Assets	1188361000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16795000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19614000	USD
CY2020Q4	us-gaap	Assets Assets	1254178000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	35781000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13158000	USD
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	19566000	USD
CY2020Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	18308000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20474000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7633000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	59678000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58154000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	47346000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	87194000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2561000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2783000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10967000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10548000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	213168000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	217392000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17192000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19744000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	216064000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	230550000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	204177000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	193036000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	26183000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	33429000	USD
CY2021Q4	mcs	Other Long Term Obligations OtherLongTermObligations	57963000	USD
CY2020Q4	mcs	Other Long Term Obligations OtherLongTermObligations	61304000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2020	mcs	Revenue From Reimbursement RevenueFromReimbursement	17202000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	145656000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153529000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	289306000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	331897000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11444000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14933000	USD
CY2021Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	454993000	USD
CY2020Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	501683000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	48111	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	124758	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1379000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2960000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	453614000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	498723000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	453614000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	498723000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1188361000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1254178000	USD
CY2021	mcs	Revenues Other Than Cost Reimbursements RevenuesOtherThanCostReimbursements	439473000	USD
CY2020	mcs	Revenues Other Than Cost Reimbursements RevenuesOtherThanCostReimbursements	220486000	USD
CY2019	mcs	Revenues Other Than Cost Reimbursements RevenuesOtherThanCostReimbursements	783705000	USD
CY2021	mcs	Revenue From Reimbursement RevenueFromReimbursement	18771000	USD
CY2019	mcs	Revenue From Reimbursement RevenueFromReimbursement	37158000	USD
CY2021	us-gaap	Revenues Revenues	458244000	USD
CY2020	us-gaap	Revenues Revenues	237688000	USD
CY2019	us-gaap	Revenues Revenues	820863000	USD
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	16069000	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	11074000	USD
CY2019	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	24583000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63350000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51046000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73522000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72127000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75052000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72277000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	25594000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	26866000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	26099000	USD
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	18473000	USD
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	23560000	USD
CY2019	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	21871000	USD
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	23817000	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	17288000	USD
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	41065000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5766000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24676000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1874000	USD
CY2021	mcs	Reimbursed Costs ReimbursedCosts	18771000	USD
CY2020	mcs	Reimbursed Costs ReimbursedCosts	17202000	USD
CY2019	mcs	Reimbursed Costs ReimbursedCosts	37158000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	499696000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	416110000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	752672000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-41452000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-178422000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	68191000	USD
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	599000	USD
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	564000	USD
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	1379000	USD
CY2021	us-gaap	Interest Expense InterestExpense	18702000	USD
CY2020	us-gaap	Interest Expense InterestExpense	16275000	USD
CY2019	us-gaap	Interest Expense InterestExpense	11791000	USD
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2510000	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	986000	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1921000	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3163000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	856000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1149000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-92000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1539000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-274000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17542000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17380000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13756000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58994000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-195802000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54435000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15701000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-70936000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12320000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-43293000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-124866000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	42115000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-23000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	98000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43293000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-124843000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	42017000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-43293000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-124866000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	42115000	USD
CY2021	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax	687000	USD
CY2020	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax	-993000	USD
CY2019	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax	-1833000	USD
CY2021	mcs	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Loss Arising During Period Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansLossArisingDuringPeriodNetOfTax	-1943000	USD
CY2020	mcs	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Loss Arising During Period Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansLossArisingDuringPeriodNetOfTax	2813000	USD
CY2019	mcs	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Loss Arising During Period Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansLossArisingDuringPeriodNetOfTax	5484000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax	342000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax	259000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax	109000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	969000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	732000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	327000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	9000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-335000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-300000	USD
CY2021	mcs	Other Comprehensive Income Loss Derivatives Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossDerivativesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-25000	USD
CY2020	mcs	Other Comprehensive Income Loss Derivatives Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossDerivativesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	949000	USD
CY2019	mcs	Other Comprehensive Income Loss Derivatives Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossDerivativesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	853000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	195000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	263000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	44000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	552000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	745000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	120000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3489000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2285000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5890000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-39804000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-127151000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	36225000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-23000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	98000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39804000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-127128000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36127000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	490119000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14663000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1520000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1119000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1181000	USD
CY2019	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	417000	USD
CY2019	mcs	Stock Issued During Period Value Non Vested Stock StockIssuedDuringPeriodValueNonVestedStock	0	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3523000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	109197000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-109000	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	185000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	36225000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	621458000	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3921000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	379000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	696000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1315000	USD
CY2020	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	162000	USD
CY2020	mcs	Stock Issued During Period Value Non Vested Stock StockIssuedDuringPeriodValueNonVestedStock	0	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4385000	USD
CY2020	mcs	Equity Component Of Issuance Of Convertible Notes Net Of Tax And Issuance Costs EquityComponentOfIssuanceOfConvertibleNotesNetOfTaxAndIssuanceCosts	16511000	USD
CY2020	mcs	Capped Call Transactions Net Of Tax CappedCallTransactionsNetOfTax	12495000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	0	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-127151000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	498723000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1530000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1391000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1011000	USD
CY2021	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	38000	USD
CY2021	mcs	Stock Issued During Period Value Non Vested Stock StockIssuedDuringPeriodValueNonVestedStock	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9316000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-39804000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	453614000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-43293000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-124866000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	42115000	USD
CY2021	mcs	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	-92000	USD
CY2020	mcs	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	-1539000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3163000	USD
CY2019	mcs	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	-274000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	200000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	856000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1149000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5766000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24676000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1874000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72127000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75052000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72277000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2198000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2235000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	285000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9316000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4385000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3523000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15843000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-38836000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9111000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1689000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2969000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1011000	USD
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1011000	USD
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1315000	USD
CY2019	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1181000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	22055000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-23106000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	3781000	USD
CY2021	mcs	Increase Decrease In Government Grant Receivable IncreaseDecreaseInGovernmentGrantReceivable	-578000	USD
CY2020	mcs	Increase Decrease In Government Grant Receivable IncreaseDecreaseInGovernmentGrantReceivable	4913000	USD
CY2019	mcs	Increase Decrease In Government Grant Receivable IncreaseDecreaseInGovernmentGrantReceivable	0	USD
CY2020	mcs	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	-9185000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2255000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3476000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1102000	USD
CY2021	mcs	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	5325000	USD
CY2019	mcs	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	3355000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	21501000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-32131000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9733000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	8508000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1467000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	67000	USD
CY2021	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	1258000	USD
CY2020	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-2305000	USD
CY2019	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	1664000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	12841000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10422000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	508000	USD
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1300000	USD
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-3630000	USD
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2541000	USD
CY2021	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	89544000	USD
CY2020	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	56312000	USD
CY2019	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	99364000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46251000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68554000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	141479000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17082000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21363000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64086000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	30081000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10883000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-199000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	22145000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4485000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	22000	USD
CY2021	mcs	Payments To Acquire Capital In Joint Venture PaymentsToAcquireCapitalInJointVenture	2427000	USD
CY2020	mcs	Payments To Acquire Capital In Joint Venture PaymentsToAcquireCapitalInJointVenture	28000	USD
CY2019	mcs	Payments To Acquire Capital In Joint Venture PaymentsToAcquireCapitalInJointVenture	0	USD
CY2021	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	377000	USD
CY2020	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	5184000	USD
CY2019	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	0	USD
CY2021	mcs	Purchase Of Trading Securities PurchaseOfTradingSecurities	3080000	USD
CY2020	mcs	Purchase Of Trading Securities PurchaseOfTradingSecurities	801000	USD
CY2019	mcs	Purchase Of Trading Securities PurchaseOfTradingSecurities	0	USD
CY2021	mcs	Life Insurance Premium Reimbursement LifeInsurancePremiumReimbursement	11411000	USD
CY2020	mcs	Life Insurance Premium Reimbursement LifeInsurancePremiumReimbursement	0	USD
CY2019	mcs	Life Insurance Premium Reimbursement LifeInsurancePremiumReimbursement	0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	461000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-450000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12073000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93946000	USD
CY2021	mcs	Proceeds From Long Term Borrowing Lines Of Credit ProceedsFromLongTermBorrowingLinesOfCredit	178500000	USD
CY2020	mcs	Proceeds From Long Term Borrowing Lines Of Credit ProceedsFromLongTermBorrowingLinesOfCredit	221500000	USD
CY2019	mcs	Proceeds From Long Term Borrowing Lines Of Credit ProceedsFromLongTermBorrowingLinesOfCredit	335000000	USD
CY2021	mcs	Repayment Of Borrowings On Revolving Credit Facility RepaymentOfBorrowingsOnRevolvingCreditFacility	178500000	USD
CY2020	mcs	Repayment Of Borrowings On Revolving Credit Facility RepaymentOfBorrowingsOnRevolvingCreditFacility	302500000	USD
CY2019	mcs	Repayment Of Borrowings On Revolving Credit Facility RepaymentOfBorrowingsOnRevolvingCreditFacility	333000000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	90800000	USD
CY2019	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	40346000	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2955000	USD
CY2019	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2021	mcs	Proceeds From Convertible Debt On Senior Notes ProceedsFromConvertibleDebtOnSeniorNotes	0	USD
CY2020	mcs	Proceeds From Convertible Debt On Senior Notes ProceedsFromConvertibleDebtOnSeniorNotes	100050000	USD
CY2019	mcs	Proceeds From Convertible Debt On Senior Notes ProceedsFromConvertibleDebtOnSeniorNotes	0	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10717000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9447000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24620000	USD
CY2021	mcs	Proceeds From Long Term Lines Of Credit On Ppp Loans ProceedsFromLongTermLinesOfCreditOnPppLoans	0	USD
CY2020	mcs	Proceeds From Long Term Lines Of Credit On Ppp Loans ProceedsFromLongTermLinesOfCreditOnPppLoans	3424000	USD
CY2019	mcs	Proceeds From Long Term Lines Of Credit On Ppp Loans ProceedsFromLongTermLinesOfCreditOnPppLoans	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2774000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2007000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2544000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	208000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7560000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-417000	USD
CY2020	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-534000	USD
CY2019	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-702000	USD
CY2021	mcs	Exercise Of Stock Options ExerciseOfStockOptions	594000	USD
CY2020	mcs	Exercise Of Stock Options ExerciseOfStockOptions	379000	USD
CY2019	mcs	Exercise Of Stock Options ExerciseOfStockOptions	1520000	USD
CY2021	mcs	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	0	USD
CY2020	mcs	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	16908000	USD
CY2019	mcs	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	0	USD
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	5145000	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	19311000	USD
CY2021	mcs	Distributions To Noncontrolling Interest DistributionsToNoncontrollingInterest	0	USD
CY2020	mcs	Distributions To Noncontrolling Interest DistributionsToNoncontrollingInterest	0	USD
CY2019	mcs	Distributions To Noncontrolling Interest DistributionsToNoncontrollingInterest	185000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47168000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	69097000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43842000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9966000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11530000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3691000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14088000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25618000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21927000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24054000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14088000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25618000	USD
CY2021	mcs	Change In Accounts Payable For Additions To Property And Equipment ChangeInAccountsPayableForAdditionsToPropertyAndEquipment	1122000	USD
CY2020	mcs	Change In Accounts Payable For Additions To Property And Equipment ChangeInAccountsPayableForAdditionsToPropertyAndEquipment	-4081000	USD
CY2019	mcs	Change In Accounts Payable For Additions To Property And Equipment ChangeInAccountsPayableForAdditionsToPropertyAndEquipment	2185000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span>
CY2021Q4	us-gaap	Inventory Net InventoryNet	4913000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3434000	USD
CY2021	us-gaap	Depreciation Depreciation	72044000	USD
CY2020	us-gaap	Depreciation Depreciation	75067000	USD
CY2019	us-gaap	Depreciation Depreciation	72244000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	75188000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	75282000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	43170000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	32205000	USD
CY2021	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	USD
CY2020	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	USD
CY2019	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0	USD
CY2021	us-gaap	Goodwill Subsequent Recognition Of Deferred Tax Asset GoodwillSubsequentRecognitionOfDeferredTaxAsset	93000	USD
CY2020	us-gaap	Goodwill Subsequent Recognition Of Deferred Tax Asset GoodwillSubsequentRecognitionOfDeferredTaxAsset	94000	USD
CY2019	us-gaap	Goodwill Subsequent Recognition Of Deferred Tax Asset GoodwillSubsequentRecognitionOfDeferredTaxAsset	93000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	75095000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	75188000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	75282000	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	23000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	48000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	53000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2198000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2235000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	285000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153529000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	331897000	USD
CY2021	mcs	Percentage Of Cash Dividends PercentageOfCashDividends	1.10
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43293000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-124843000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	42017000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31360000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31042000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30656000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	496000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31360000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31042000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31152000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1999000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1706000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	324000	shares
CY2021Q4	mcs	Accumulated Other Comprehensive Income Loss On Interest Rate Swap Agreements Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossOnInterestRateSwapAgreementsAdjustmentNetOfTax	-509000	USD
CY2020Q4	mcs	Accumulated Other Comprehensive Income Loss On Interest Rate Swap Agreements Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossOnInterestRateSwapAgreementsAdjustmentNetOfTax	-1086000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	10935000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	13847000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11444000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14933000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	193036000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	33429000	USD
CY2021	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. Impact of COVID-19 Pandemic</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has had an unprecedented impact on the world and both of the Company’s business segments. The situation continues to be volatile and the social and economic effects are widespread. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, the Company’s businesses are significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and customers’ reactions or responses to such actions. These actions have included, among other things, declaring national and state emergencies, encouraging social distancing, restricting freedom of movement and congregation, mandating non-essential business closures, issuing curfews, limiting business capacity, mandating mask-wearing and/or proof of vaccination, and issuing shelter-in-place, quarantine and stay-at-home orders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company began fiscal 2021 with approximately 52% of its theatres open. As state and local governments eased restrictions in several of the Company’s markets and movie studios released several new films, the Company gradually reopened theatres during the first half of fiscal 2021. The Company ended fiscal 2021 with all of its theatres open. The majority of the reopened theatres operated with reduced operating days (Fridays, Saturdays, Sundays and Tuesdays) and </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduced operating hours during the fiscal 2021 first quarter. By the end of May 2021, the Company had returned the vast majority of its theatres to normal operating days (seven days per week) and operating hours. During fiscal 2021, all of the reopened theatres operated at significantly reduced attendance levels compared to prior pre-COVID-19 pandemic years due to customer concerns related to the COVID-19 pandemic and a reduction in the number of new films released. While still below pre-COVID-19 levels, attendance has gradually improved beginning in June 2021 as the number of vaccinated individuals increased, more films were released, and customer willingness to return to movie theatres increased.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company began fiscal 2021 with all eight of its company-owned hotels and all but one of its managed hotels open. The majority of the Company’s restaurants and bars in its hotels and resorts were open during fiscal 2021, operating under applicable state and local restrictions and guidelines, and in some cases, reduced operating hours. The majority of the Company’s hotels and restaurants are generating reduced revenues as compared to prior pre-COVID-19 pandemic years, although hotel occupancy increased throughout the fiscal 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the COVID-19 crisis began, the Company has been working proactively to preserve cash and enhance liquidity. In fiscal 2020, the Company obtained additional financing and modified previously existing debt covenants. Additionally, early in the Company’s fiscal 2021 third quarter, in conjunction with an amendment to its revolving credit agreement, the Company paid down a portion of its term loan facility, reducing the balance of its short-term borrowings from approximately $83,500 to $50,000, and modified its previously existing debt covenants. In conjunction with the amendment, the maturity date of the term loan facility was extended to September 22, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in its first quarter of fiscal 2021, the Company received the remaining $5,900 of requested tax refunds from its fiscal 2019 tax return. During the first quarter of fiscal 2021, the Company filed income tax refund claims of $24,200 related to its fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. The Company received approximately $1,800 of this refund in July 2021. Due to significant delays in processing refunds by the Internal Revenue Service, the remaining $22,300 refund, plus interest, was not received until February 2022. The Company also generated additional income tax loss carryforwards during fiscal 2021 that will benefit future years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2020 and continuing into fiscal 2021, a number of states elected to provide grants to certain businesses most impacted by the COVID-19 pandemic, utilizing funds received by the applicable state under provisions of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”) or subsequent federal relief programs. The Company received $4,900 of these prior year grants in January 2021. The Company was awarded and received an additional $1,300 in theatre grants during the first quarter of fiscal 2021 and an additional $1,900 in hotel grants during the third quarter of fiscal 2021. The Company was also awarded an additional $4,500 in theatre grants during the fourth quarter of fiscal 2021, the majority of which was received in January 2022. All of these grants further contributed to the Company’s current liquidity position. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2021, the Company had a cash balance of $17,658 and $221,449 of availability under its $225,000 revolving credit facility. The Company believes that with its liquidity position, combined with the expected receipt of income tax refunds and proceeds from the sale of surplus real estate, it is positioned to meet its obligations as they come due and to comply with its debt covenants for at least 12 months from the issuance date of these consolidated financial statements. The Company’s estimates and assumptions related to future forecasted results of the Company are subject to inherent risk and uncertainty due to the ongoing impact of the COVID-19 pandemic. The Company cannot assure that the impact of the COVID-19 pandemic will cease to have a material adverse effect on both its theatre and hotels and resorts businesses, results of operations, cash flows, financial condition, and debt covenant compliance.</span></div>
CY2020Q4	mcs	Percentage Of Theatres Open PercentageOfTheatresOpen	0.52
CY2021Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	83500000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	50000000	USD
CY2021Q2	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	5900000	USD
CY2021Q2	mcs	Income Tax Refund Claims Cares Act IncomeTaxRefundClaimsCaresAct	24200000	USD
CY2021Q3	mcs	Proceeds From Income Tax Refunds Provisions Of Coronavirus Aid Relief And Economic Security Act ProceedsFromIncomeTaxRefundsProvisionsOfCoronavirusAidReliefAndEconomicSecurityAct	1800000	USD
CY2021Q1	mcs	Grants Received To Offset Other Operating Expenses GrantsReceivedToOffsetOtherOperatingExpenses	4900000	USD
CY2021Q2	mcs	Grants Awarded To Companys Theatres GrantsAwardedToCompanysTheatres	1300000	USD
CY2021Q3	mcs	Grants Awarded To Company S Hotels GrantsAwardedToCompanySHotels	1900000	USD
CY2021Q4	mcs	Grants Awarded To Companys Theatres GrantsAwardedToCompanysTheatres	4500000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17658000	USD
CY2021	mcs	Revenue From Reimbursement RevenueFromReimbursement	18771000	USD
CY2021	us-gaap	Revenues Revenues	458244000	USD
CY2020	mcs	Revenue From Reimbursement RevenueFromReimbursement	17202000	USD
CY2020	us-gaap	Revenues Revenues	237688000	USD
CY2019	mcs	Revenue From Reimbursement RevenueFromReimbursement	37158000	USD
CY2019	us-gaap	Revenues Revenues	820863000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	39144000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	37307000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	43200000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13968000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13579000	USD
CY2021Q4	mcs	Impaired Asset Fair Value ImpairedAssetFairValue	11689000	USD
CY2020Q4	mcs	Impaired Asset Fair Value ImpairedAssetFairValue	33313000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1001000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1284000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8981000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	405000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	19921000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5954000	USD
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	28902000	USD
CY2020Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	6359000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1509450000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1521906000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	738258000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	673578000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	771192000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	848328000	USD
CY2021Q4	mcs	Split Dollar Life Insurance Policies SplitDollarLifeInsurancePolicies	0	USD
CY2020Q4	mcs	Split Dollar Life Insurance Policies SplitDollarLifeInsurancePolicies	11411000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6987000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7297000	USD
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5702000	USD
CY2020Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	12393000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12689000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31101000	USD
CY2021Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	24388000	USD
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	24482000	USD
CY2021Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	90000000	USD
CY2020Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	100000000	USD
CY2020Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	39000	USD
CY2021Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	39000	USD
CY2020Q4	mcs	Interest Rate Of Unsecured Term Note InterestRateOfUnsecuredTermNote	0.0575
CY2020	mcs	Interest Rate Of Unsecured Term Note InterestRateOfUnsecuredTermNote	0.0575
CY2021Q4	mcs	Long Term Unsecured Notes Payable LongTermUnsecuredNotesPayable	1356000	USD
CY2020Q4	mcs	Long Term Unsecured Notes Payable LongTermUnsecuredNotesPayable	1735000	USD
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	100050000	USD
CY2020Q4	us-gaap	Convertible Debt ConvertibleDebt	100050000	USD
CY2021Q4	mcs	Long Term Debt Under Payroll Protection Program Cares Act LongTermDebtUnderPayrollProtectionProgramCaresAct	3181000	USD
CY2020Q4	mcs	Long Term Debt Under Payroll Protection Program Cares Act LongTermDebtUnderPayrollProtectionProgramCaresAct	3424000	USD
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3831000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3684000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	215144000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	226007000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10967000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10548000	USD
CY2021Q4	mcs	Long Term Debt Discount LongTermDebtDiscount	0	USD
CY2020Q4	mcs	Long Term Debt Discount LongTermDebtDiscount	22423000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	204177000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	193036000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	47346000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	87194000	USD
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	262490000	USD
CY2020Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	313201000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	47346000	USD
CY2021Q4	mcs	Covenant Regarding Ebitda CovenantRegardingEbitda	10000000	USD
CY2021Q4	mcs	Minimum Reduction In Amount Of Liquidity For Covenant MinimumReductionInAmountOfLiquidityForCovenant	50000000	USD
CY2021	mcs	Covenant Regarding Capital Expenditure CovenantRegardingCapitalExpenditure	40000000	USD
CY2021Q4	mcs	Maximum Limit For Cash On Hand For Not Paying Revolving Loans MaximumLimitForCashOnHandForNotPayingRevolvingLoans	75000000	USD
CY2020Q3	mcs	Percentage Of Fee Payable To Each Note Holder PercentageOfFeePayableToEachNoteHolder	0.00975
CY2020Q3	mcs	Percentage Of Fee Payable To Each Note Holder Quarterly PercentageOfFeePayableToEachNoteHolderQuarterly	0.0024375
CY2021	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2021	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2021	mcs	Options Trading Period OptionsTradingPeriod	P20D
CY2021	mcs	Options Threshold Trading Days OptionsThresholdTradingDays	P30D
CY2020Q3	mcs	Capped Call Transactions Cap Price CappedCallTransactionsCapPrice	17.98
CY2020Q3	mcs	Capped Call Transactions Strike Price CappedCallTransactionsStrikePrice	11.0128
CY2020Q3	mcs	Debt Instrument Convertible Conversion Premium DebtInstrumentConvertibleConversionPremium	1
CY2020Q3	us-gaap	Share Price SharePrice	8.99
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	10967000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	11028000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	11090000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	124088000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	258000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	57713000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	215144000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	14119000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	10885000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	10281000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2732000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2851000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	951000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1048000	USD
CY2021	mcs	Finance Lease Cost FinanceLeaseCost	3683000	USD
CY2020	mcs	Finance Lease Cost FinanceLeaseCost	3899000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	25489000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	25821000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	-30000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	23794000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	724000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	135000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	321000	USD
CY2021	us-gaap	Lease Cost LeaseCost	25594000	USD
CY2020	us-gaap	Lease Cost LeaseCost	26866000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2774000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2007000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	951000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1048000	USD
CY2021	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	31136000	USD
CY2020	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	17685000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1417000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2663000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10957000	USD
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0458
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0462
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0448
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3404000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	26684000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	26803000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	3162000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25468000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	3056000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	25532000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	2897000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	25179000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	2817000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	180524000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	8458000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	310190000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	77331000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	4041000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	232859000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	19753000	USD
CY2021Q4	mcs	Operating Lease Deferred Rent Payments OperatingLeaseDeferredRentPayments	2727000	USD
CY2021	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	1.10
CY2021Q4	mcs	Common Stock Vote Per Share CommonStockVotePerShare	1	vote
CY2021Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	11687500	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	61654	shares
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	37567	shares
CY2019	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	30139	shares
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	2657340	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	750000	shares
CY2021	mcs	Share Based Compensation Arrangement By Share Based Payment Award Number Of Available Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAvailableSharesAuthorized	421870	shares
CY2021	mcs	Share Based Compensation Shares Approved For Issuance ShareBasedCompensationSharesApprovedForIssuance	7437500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1851090	shares
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1997000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	771000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	531000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.74
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0170
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9316000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4385000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3523000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1127000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2234000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.87
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1641000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.46
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1450000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.25
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.84
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2234000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.42
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.21
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	728000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.47
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	329000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	41.67
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	134000	shares
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	97000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	98000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	26.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	104000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.06
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	41000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	30.58
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2533000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.87
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.47
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1641000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.46
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1119000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.76
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1001000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.38
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	802000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.22
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.96
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.79
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2486000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	24.87
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1965000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1996000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	756000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1164000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2135000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6336000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	147000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.02
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	174000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.16
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	158000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.98
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	251000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	19.63
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	42000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	26.56
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	23000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	31.43
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	39000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	38.24
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	32000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	30.69
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	69000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	9000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.77
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	357000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.32
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	147000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.02
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	174000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.16
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	3022000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2021	mcs	Retirement Savings Plan Expense RetirementSavingsPlanExpense	1696000	USD
CY2020	mcs	Retirement Savings Plan Expense RetirementSavingsPlanExpense	1718000	USD
CY2019	mcs	Retirement Savings Plan Expense RetirementSavingsPlanExpense	2311000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	48604000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	43824000	USD
CY2021	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1122000	USD
CY2020	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1095000	USD
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	1201000	USD
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	1371000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-2630000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	3806000	USD
CY2021	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	1470000	USD
CY2020	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	1492000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	46827000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	48604000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	1674000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	1401000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	45153000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	47203000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	46827000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	48604000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax	15120000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax	19125000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax	323000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit After Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax	387000	USD
CY2021Q4	mcs	Defined Benefit Plan Amounts Recognized Accumulated Other Comprehensive Income Loss DefinedBenefitPlanAmountsRecognizedAccumulatedOtherComprehensiveIncomeLoss	14797000	USD
CY2020Q4	mcs	Defined Benefit Plan Amounts Recognized Accumulated Other Comprehensive Income Loss DefinedBenefitPlanAmountsRecognizedAccumulatedOtherComprehensiveIncomeLoss	18738000	USD
CY2021	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	1122000	USD
CY2020	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	1095000	USD
CY2019	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	833000	USD
CY2021	mcs	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Interest Cost Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetInterestCostBeforeTax	1201000	USD
CY2020	mcs	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Interest Cost Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetInterestCostBeforeTax	1371000	USD
CY2019	mcs	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Net Interest Cost Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetInterestCostBeforeTax	1485000	USD
CY2021	mcs	Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax	-1311000	USD
CY2020	mcs	Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax	-990000	USD
CY2019	mcs	Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax Othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditacturialgainlossandtransitionassetobligationbeforetax	-436000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	3634000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	3456000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	2754000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	10935000	USD
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-11174000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	13847000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-14133000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	42853000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	43548000	USD
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-2630000	USD
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	3806000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	1375000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	1055000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax	64000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax	64000	USD
CY2021	mcs	Defined Benefit Plan Actuarial Gain Loss After Amortization Before Tax DefinedBenefitPlanActuarialGainLossAfterAmortizationBeforeTax	-3941000	USD
CY2020	mcs	Defined Benefit Plan Actuarial Gain Loss After Amortization Before Tax DefinedBenefitPlanActuarialGainLossAfterAmortizationBeforeTax	2815000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	1697000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0285
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0245
CY2021Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.0400
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.0400
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0245
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0310
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0415
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0400
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0400
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0400
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	1759000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	1975000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	2204000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	2357000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	15043000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	17669000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	16685000	USD
CY2021Q4	mcs	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	59622000	USD
CY2020Q4	mcs	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	64055000	USD
CY2021Q4	mcs	Deferred Tax Assets Gift Card Liabilities DeferredTaxAssetsGiftCardLiabilities	7318000	USD
CY2020Q4	mcs	Deferred Tax Assets Gift Card Liabilities DeferredTaxAssetsGiftCardLiabilities	5098000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	24166000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	21525000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6876000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	876000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	115651000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	108239000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2415000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	113236000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	108239000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	73898000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	82964000	USD
CY2021Q4	mcs	Deferred Tax Liabilities Operating Leases DeferredTaxLiabilitiesOperatingLeases	55489000	USD
CY2020Q4	mcs	Deferred Tax Liabilities Operating Leases DeferredTaxLiabilitiesOperatingLeases	58704000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	129387000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	141668000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	16151000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	33429000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10032000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	26183000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	33429000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	16151000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	33429000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2415000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	13000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-32626000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1187000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	129000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	526000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2041000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12629000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-24751000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9228000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3214000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-14085000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-136000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15701000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-70936000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12320000	USD
CY2021	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.266
CY2020	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.362
CY2019	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.227
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11976000	USD
CY2020	mcs	Differed Income Tax Expense Benefit Cares Act And Tax Accounting Changes DifferedIncomeTaxExpenseBenefitCARESActAndTaxAccountingChanges	8095000	USD
CY2020	mcs	Effective Income Tax Rate Reconciliation Cares Act Percent EffectiveIncomeTaxRateReconciliationCARESActPercent	0.260
CY2020Q4	mcs	Income Tax Refund Claims Cares Act IncomeTaxRefundClaimsCaresAct	37400000	USD
CY2021Q4	mcs	Income Tax Refund Claims Cares Act IncomeTaxRefundClaimsCaresAct	24200000	USD
CY2020	mcs	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCaresAct	31500000	USD
CY2021	mcs	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCaresAct	7800000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	mcs	Effective Income Tax Rate Reconciliation Change In Tax From Cares Act And Accounting Method Changes EffectiveIncomeTaxRateReconciliationChangeInTaxFromCaresActAndAccountingMethodChanges	0
CY2020	mcs	Effective Income Tax Rate Reconciliation Change In Tax From Cares Act And Accounting Method Changes EffectiveIncomeTaxRateReconciliationChangeInTaxFromCaresActAndAccountingMethodChanges	0.103
CY2019	mcs	Effective Income Tax Rate Reconciliation Change In Tax From Cares Act And Accounting Method Changes EffectiveIncomeTaxRateReconciliationChangeInTaxFromCaresActAndAccountingMethodChanges	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.067
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.055
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.016
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	-0.002
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.027
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.041
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.011
CY2021	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.266
CY2020	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.362
CY2019	mcs	Effective Income Tax Rate EffectiveIncomeTaxRate	0.227
CY2021	mcs	Proceeds From Income Tax Paid Refunds ProceedsFromIncomeTaxPaidRefunds	-8316000	USD
CY2020	mcs	Proceeds From Income Tax Paid Refunds ProceedsFromIncomeTaxPaidRefunds	-33275000	USD
CY2019	mcs	Proceeds From Income Tax Paid Refunds ProceedsFromIncomeTaxPaidRefunds	3062000	USD
CY2021	mcs	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCaresAct	7800000	USD
CY2020	mcs	Income Tax Expense Benefit Net Operating Loss Cares Act IncomeTaxExpenseBenefitNetOperatingLossCaresAct	31500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021	mcs	Income Tax Examination Interest Income IncomeTaxExaminationInterestIncome	60000	USD
CY2020	mcs	Income Tax Examination Interest Income IncomeTaxExaminationInterestIncome	296000	USD
CY2019	mcs	Income Tax Examination Interest Income IncomeTaxExaminationInterestIncome	1000	USD
CY2021Q4	mcs	Commitments To Complete Contracts In Process Value CommitmentsToCompleteContractsInProcessValue	11776000	USD
CY2021	us-gaap	Revenues Revenues	458244000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-41452000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72127000	USD
CY2021Q4	us-gaap	Assets Assets	1188361000	USD
CY2021Q4	mcs	Capital Expenditures And Acquisitions CapitalExpendituresAndAcquisitions	17082000	USD
CY2020	us-gaap	Revenues Revenues	237688000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-178422000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75052000	USD
CY2020Q4	us-gaap	Assets Assets	1254178000	USD
CY2020Q4	mcs	Capital Expenditures And Acquisitions CapitalExpendituresAndAcquisitions	21363000	USD
CY2019	us-gaap	Revenues Revenues	820863000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	68191000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72277000	USD
CY2019Q4	us-gaap	Assets Assets	1359186000	USD
CY2019Q4	mcs	Capital Expenditures And Acquisitions CapitalExpendituresAndAcquisitions	94167000	USD
CY2021	dei	Auditor Firm AuditorFirmId	34

Files In Submission

Name	View Source	Status
0000062234-22-000010-index-headers.html	Edgar Link	pending
0000062234-22-000010-index.html	Edgar Link	pending
0000062234-22-000010.txt	Edgar Link	pending
0000062234-22-000010-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mcs-20211230.htm	Edgar Link	pending
mcs-20211230.xsd	Edgar Link	pending
mcs-20211230xex21.htm	Edgar Link	pending
mcs-20211230xex23.htm	Edgar Link	pending
mcs-20211230_cal.xml	Edgar Link	unprocessable
mcs-20211230_def.xml	Edgar Link	unprocessable
mcs-20211230_g1.jpg	Edgar Link	pending
mcs-20211230_htm.xml	Edgar Link	completed
mcs-20211230_lab.xml	Edgar Link	unprocessable
mcs-20211230_pre.xml	Edgar Link	unprocessable
mcs20211230-ex1022.htm	Edgar Link	pending
mcs20211230-ex311.htm	Edgar Link	pending
mcs20211230-ex312.htm	Edgar Link	pending
mcs20211230-ex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCS
MARCUS CORP Stock $mcs

2021 Q4 Form 10-K Financial Statement

#000006223422000010 Filed on March 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCS MARCUS CORP Stock $mcs

2021 Q4 Form 10-K Financial Statement

#000006223422000010 Filed on March 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCS
MARCUS CORP Stock $mcs